Acadia Pharmaceuticals Inc (ACAD)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 136.49M | 118.46M | 165.24M | 211.7M | 231.04M | 205.83M | 241.96M | 250.4M |
Operating Income | -46.06M | -53.58M | 3.04M | -57.78M | 34.94M | 15.21M | 30.44M | 31.64M |
Pre Tax Income | -40.89M | -44.94M | 6.34M | -52.14M | 39.7M | 21M | 37.18M | 38.81M |
Net Income | -41.73M | -43.02M | 1.11M | -65.18M | 45.8M | 16.56M | 33.39M | 32.77M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -46.06M | -53.58M | 3.04M | -52.67M | 34.94M | 15.5M | 30.82M | 32.22M |
EBITDA | -45.57M | -53.16M | 4.8M | -56.05M | 36.58M | 20.74M | 33.01M | 34.21M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 17.33M | 124.9M | 223.81M | 339.08M | 441.76M | 484.15M | 517.24M | 726.44M |
Operating Income | -272.82M | -292.41M | -247.44M | -246.55M | -286.59M | -170.44M | -223.6M | -73.38M |
Pre Tax Income | -270.05M | -288.28M | -243.94M | -234.38M | -280.97M | -167.52M | -213.44M | -51.04M |
Net Income | -271.39M | -289.4M | -245.19M | -235.26M | -281.58M | -167.87M | -215.98M | -61.29M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -2.236 | -2.326 | -1.704 | -1.515 | -1.764 | -1.043 | -1.333 | -0.373 |
EBIT | -272.82M | -292.41M | -247.44M | -246.55M | -286.59M | -170.44M | -223.6M | -73.38M |
EBITDA | -270.99M | -289.7M | -244.44M | -243.78M | -283.65M | -167.1M | -221.57M | -67.83M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.